Hs.137007 is a novel epigenetic marker hypermethylated and up-regulated in breast cancer

International Journal of Oncology

Volumn 36, Issue 5, 2010, Pages 1105-1111

  Kim, Tae Woo ^a   Kim, Yoo Jung ^a   Lee, Hyun Ji ^a   Min, Sun Young ^b   Kang, Han Sung ^b   Kim, Sun Jung ^a  

^a Dongguk University   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Breast cancer; Digital differential display; Hs.137007; Methylation; Unigene

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENETIC MARKER; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 77950382469     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000592     Document Type: Article

References (34)

1. Schones D and Zhao K: Genome-wide approaches to studying chromatin modifications. Nat Rev Genet 9: 179-191, 2008.
2. Fazzari M and Greally J: Epigenomics: beyond CpG islands. Nat Rev Genet 5: 446-455, 2004.
3. Bird A: DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21, 2002.
4. Blelloch R, Wang Z, Meissner A, Pollard S, Smith A and Jaenisch R: Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells 24: 2007-2013, 2006.
5. Widschwendter M and Jones P: DNA methylation and breast carcinogenesis. Oncogene 21: 5462-5482, 2002.
6. Rodenhiser D, Andrews J, Kennette W, et al: Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Breast Cancer Res 10: R62, 2008.
7. Singh P, Yang M, Dai H, et al: Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers. Mol Cancer Res 6: 1710-1717, 2008.
8. Ito Y, Koessler T, Ibrahim A, et al: Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum Mol Genet 17: 2633-2643, 2008.
9. Wu H, Chen Y, Liang J, et al: Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438: 981-987, 2005.
10. Yu J, Koujak S, Nagase S, et al: PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene 27: 4657-4665, 2008.
11. Ai L, Kim W, Kim T, et al: Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. Cancer Res 66: 7899-7909, 2006.
12. Wolf I, O'Kelly J, Rubinek T, et al: 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Cancer Res 66: 7818-7823, 2006.
13. Rivenbark A, Jones W, Risher J and Coleman W: DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells. Epigenetics 1: 32-44, 2006.
14. Miyamoto K, Fukutomi T, Akashi-Tanaka S, et al: Identification of 20 genes aberrantly methylated in human breast cancers. Int J Cancer 116: 407-414, 2005.
15. Nabilsi N, Broaddus R and Loose D: DNA methylation inhibits p53-mediated survivin repression. Oncogene 28: 2046-2050, 2009.
16. Cox G, Gutkin D, Haas M and Cosgrove D: Isolation of an Alu repetitive DNA binding protein and effect of CpG methylation on binding to its recognition sequence. Biochim Biophys Acta 1396: 67-87, 1998.
17. Arapshian A, Kuppumbatti Y and Mira-y-Lopez R: Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells. Oncogene 19: 4066-4070, 2000.
18. Witcher M and Emerson B: Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol Cell 34: 271-284, 2009.
19. Schumacher A, Kapranov P, Kaminsky Z, et al: Microarray-based DNA methylation profiling: technology and applications. Nucleic Acids Res 34: 528-542, 2006.
20. Zighelboim I, Goodfellow P, Schmidt A, et al: Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers. Clin Cancer Res 13: 2882-2889, 2007.
21. Wang Y, Yu Q, Cho A, et al: Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia 7: 748-760, 2005.
22. Yang H, Cho E, Han K, Kim H and Kim S: Characterization of a novel mouse brain gene (mbu-1) identified by digital differential display. Gene 395: 144-150, 2007.
23. Kang J, Kim S, Noh D, Choe K, Lee E and Kang H: The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer. J Mol Med 79: 648-655, 2001.
24. Ji JW, Yang HL and Kim SJ: Analysis of cag-8: a novel poly(Q)-encoding gene in the mouse brain. Biochem Biophys Res Commun 346: 1254-1260, 2006.
25. Xue F and Cooley L: Kelch encodes a component of intercellular bridges in Drosophila egg chambers. Cell 72: 681-693, 1993.
26. Ohmachi M, Sugimoto A, Iino Y and Yamamoto M: kel-1, a novel Kelch-related gene in Caenorhabditis elegans, is expressed in pharyngeal gland cells and is required for the feeding process. Genes Cells 4: 325-337, 1999.
27. Lai F, Orelli B, Till B, et al: Molecular characterization of KLHL3, a human homologue of the Drosophila kelch gene. Genomics 66: 65-75, 2000.
28. Adams J: Characterization of a Drosophila melanogaster orthologue of muskelin. Gene 297: 69-78, 2002.
29. Shaw R, Liloglou T, Rogers S, et al: Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 94: 561-568, 2006.
30. Ding X, Luo C, Zhou J, et al: The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation. J Cell Biochem 106: 285-295, 2009.
31. Kitadai Y, Yamazaki H, Yasui W, et al: GC factor represses transcription of several growth factor/receptor genes and causes growth inhibition of human gastric carcinoma cell lines. Cell Growth Differ 4: 291-296, 1993.
32. Morrione A, De Angelis T and Baserga R: The GC factor regulates the expression of the insulin-like growth factor-I receptor. Cell Prolif 28: 659-671, 1995.
33. Huang T, Perry M and Laux D: Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 8: 459-470, 1999.
34. Costello J, Frühwald M, Smiraglia D, et al: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24: 132-138, 2000.